REG - CVS Group plc - Exercise of Options, PDMR Dealing and TVR

CVSAnnouncement

13/10/2021 18:05

RNS Number : 0092P
  
CVS Group plc
  
13 October 2021
  
 

13 October 2021
CVS Group Plc
("CVS", the "Company" or the "Group")
Exercise of Options, PDMR Dealing and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services, announces that on 13 October 2021, options over a total of 97,491 new ordinary shares of 0.2 pence each (the "New Shares") were exercised under the CVS Group Long Term Incentive Plan (LTIP) 12 (2018/2021), at an exercise price of 0.2 pence. 
 
Richard Fairman, Chief Executive Officer, and Ben Jacklin, Chief Operating Officer, exercised options over 30,969 and 6,194 ordinary shares of 0.2p each in the Company respectively ("Ordinary Shares").  The balance of the options were exercised by certain other employees and former employees of the Company.
 
On 13 October 2021, the Company was notified that, on that date, Richard Fairman and Ben Jacklin sold 14,601 and 2,921 Ordinary Shares respectively at a price of £24.2215 per Ordinary Share.  These sale amounts are sufficient to meet the costs of exercise incurred by the PDMR option holders, including personal taxation.  
 
Following their respective option exercises and their sales of a portion of the new shares arising, Richard Fairman holds a beneficial interest in 27,818 Ordinary Shares in the Company, representing approximately 0.039 per cent of the total voting rights of the Company following the issue of the New Shares, and Ben Jacklin holds a beneficial interest in 4,709 Ordinary Shares in the Company, representing approximately 0.007 per cent of the total voting rights of the Company, calculated on the same basis.
 
Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on Tuesday 19 October, 2021.
 
Following the issue of the New Shares, the Company has a total issued share capital of 70,866,133 Ordinary Shares each carrying one voting right.  The Company holds no Ordinary Shares in treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company will be 70,866,133.  This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
 
This announcement is released by CVS Group plc and contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"), encompassing information relating to trading for the Company's current financial year, and is disclosed in accordance with the Company's obligations under UK MAR. This announcement is being made on behalf of the Company by the director named below.





Contacts:


















CVS Group plc


via MHP Communications




Richard Fairman, CEO








Jenny Farrer, Company Secretary


















Singer Capital Markets (Nominated Adviser & Broker)                 


+44 20 7496 3000




Aubrey Powell / Jen Boorer / Rachel Hayes


 














MHP Communications (Financial PR)


+44 20 3128 8549




Andrew Jaques / Rachel Mann / Charles Hirst







 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Richard Fairman
 




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Executive Officer




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CVS Group plc




b) 
 


LEI 
 
 


213800J41XDQ2NX48O05




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 
 


Ordinary shares of 0.2 pence each
 
 
GB00B2863827
 




b) 
 


Nature of the transaction 
 
 


i)          Exercise of options under LTIP 12
ii)          Partial sale of ordinary shares arising from exercise




c) 
 


Price(s) and volume(s) 
 
 


 



Price(s)
 


Volume(s)




i)          Exercise price of 0.2p
 
ii)          £24.2215


30,969
 
14,601



 
 




d) 
 


Aggregated information 
 
- Aggregated volume 
 
 
- Price 
 


N/A
 
 
 




e) 
 


Date of the transaction 
 
 


13 October 2021




f) 
 


Place of the transaction 
 
 


London Stock Exchange



 



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Ben Jacklin




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 
 


Chief Operating Officer




b) 
 


Initial notification /Amendment 
 
 


Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 
 


CVS Group plc




b) 
 


LEI 
 
 


213800J41XDQ2NX48O05




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 
 


Ordinary shares of 0.2 pence each
 
 
GB00B2863827
 




b) 
 


Nature of the transaction 
 
 


i)          Exercise of options under LTIP 12
ii)          Partial sale of ordinary shares arising from exercise




c) 
 


Price(s) and volume(s) 
 
 


 



Price(s)
 


Volume(s)




i)          Exercise price of 0.2p
 
ii)          £24.2215


6,194       
                                
2,921



 
 




d) 
 


Aggregated information 
 
- Aggregated volume 
 
 
- Price 
 


N/A
 
 
 




e) 
 


Date of the transaction 
 
 


13 October 2021




f) 
 


Place of the transaction 
 
 


London Stock Exchange



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCFLFIDIILVLIL